EP Wealth Advisors LLC Invests $310,000 in Pediatrix Medical Group, Inc. $MD

Key Points

• EP Wealth Advisors LLC has acquired a new position in Pediatrix Medical Group, Inc. by purchasing 21,399 shares, amounting to approximately $310,000.
• Pediatrix Medical Group has reported a quarterly earnings per share (EPS) of $0.53, surpassing analyst expectations of $0.42, although revenue has decreased by 7.1% year-over-year.
• Various institutional investors have increased their stakes in Pediatrix Medical Group, with 97.71% of the stock now held by institutional investors.

EP Wealth Advisors LLC acquired a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 21,399 shares of the company's stock, valued at approximately $310,000.

Other large investors have also recently modified their holdings of the company. GAMMA Investing LLC increased its position in shares of Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after buying an additional 1,765 shares during the period. AlphaQuest LLC increased its position in shares of Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after buying an additional 811 shares during the period. Squarepoint Ops LLC purchased a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $132,000. Sherbrooke Park Advisers LLC purchased a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new position in shares of Pediatrix Medical Group during the first quarter valued at about $159,000. Institutional investors own 97.71% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on MD shares. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Wall Street Zen cut shares of Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Finally, Leerink Partners boosted their price target on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a research report on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Pediatrix Medical Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $16.79.

Pediatrix Medical Group Stock Down 2.0%

MD traded down $0.34 during midday trading on Friday, reaching $16.67. The company's stock had a trading volume of 524,924 shares, compared to its average volume of 774,244. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of 12.92 and a beta of 1.30. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a 1 year low of $10.39 and a 1 year high of $17.67. The stock's 50-day moving average is $14.75 and its 200-day moving average is $14.18.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million for the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business's revenue was down 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.34 earnings per share. As a group, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.